{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:34Z","timestamp":1786119454827,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/mjt.0b013e3181ea3213","type":"journal-article","created":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T06:53:21Z","timestamp":1284533601000},"page":"446-454","source":"Crossref","is-referenced-by-count":15,"title":["Adherence to Aldosterone-Blocking Agents in Patients with Heart Failure"],"prefix":"10.1097","volume":"17","author":[{"given":"Jay","family":"Margolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2005.11.005","article-title":"2006 Comprehensive heart failure practice guideline.","volume":"12","year":"2006","journal-title":"J Card Fail"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology.","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.165.1.62","article-title":"Statin use and survival outcomes in elderly patients with heart failure.","volume":"165","author":"Ray","year":"2005","journal-title":"Arch Intern Med"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacc.2003.07.049","article-title":"Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.","volume":"43","author":"Horwich","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The Euro Heart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe: part 2: treatment.","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0002-9149(96)00294-9","article-title":"Concomitant factors of decompensation in chronic heart failure.","volume":"78","author":"Opasich","year":"1996","journal-title":"Am J Cardiol"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","article-title":"Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.","volume":"24","author":"Wang","year":"1994","journal-title":"Hypertension"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","article-title":"Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.","volume":"19","author":"Duprez","year":"1998","journal-title":"Eur Heart J"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.104.527549","article-title":"Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.","volume":"112","author":"Masoudi","year":"2005","journal-title":"Circulation"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2125.2004.02187.x","article-title":"Tolerability of spironolactone in patients with chronic heart failure: a cautionary message.","volume":"58","author":"Witham","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejheart.2005.07.002","article-title":"Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.","volume":"7","author":"McMurray","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/aje\/154.9.854","article-title":"Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.","volume":"154","author":"Schneeweiss","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R20-2-20210202","first-page":"110","article-title":"A comparison of comorbidity measurements to predict healthcare expenditures.","volume":"12","author":"Farley","year":"2006","journal-title":"Am J Manag Care"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCULATIONAHA.106.669101","article-title":"Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.","volume":"116","author":"Gislason","year":"2007","journal-title":"Circulation"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","article-title":"Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.","volume":"27","author":"Gislason","year":"2006","journal-title":"Eur Heart J"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181ea3213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:34:39Z","timestamp":1786041279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201009000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181ea3213","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}